Try GOLD - Free
Centre wants to review safety, efficacy norms for 13 'very old' drugs
Mint New Delhi
|February 28, 2025
The government body charged with setting quality standards for drugs has launched a review of the safety and efficacy norms for 13 commonly used but "very old" drugs and asked pharmaceutical companies to submit their manufacturing licence approval letters.
The Indian Pharmacopoeia Commission (IPC), part of the Drugs Controller General of India, said the letter should be issued by either the Central Drugs Standard Control Organisation (CDSCO) or a state licensing authority.
The Commission is set to incorporate new standards into Indian Pharmacopoeia—the handbook that lists efficacy and safety standards for all drugs produced in the country that companies have to follow.
The 13 drugs include Clindamycin Lotion used for skin allergies, Nitrofurantoin Oral Suspension used to treat infections of the bladder and Dexamethasone, used to treat inflammation of the skin, joints, lungs and other organs. The details have to be furnished by Friday, 28 February.
This story is from the February 28, 2025 edition of Mint New Delhi.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint New Delhi
Mint New Delhi
Mining reform plan hits state pushback
Revenue loss fears rise; high upfront fees may aid large steel firms
3 mins
November 19, 2025
Mint New Delhi
CVC, EQT in talks to buy ValueLabs at $1 bn valuation
Global private equity majors EQT Partners, PAG, Blackstone and CVC are among suitors in talks to acquire a controlling stake in software services firm ValueLabs from the promoters, according to three people with information on the deal.
2 mins
November 19, 2025
Mint New Delhi
How will vertical property cards help flat owners?
Maharashtra plans to include the names of individual flat owners in land records and issue 'vertical property cards' to them, stating their share in a property. These cards will provide a clear legal proof of ownership, benefiting owners, buyers and lenders.Mint explains how.
2 mins
November 19, 2025
Mint New Delhi
Groww beats BSE m-cap as stock scarcity sparks frenzy
A series of short squeezes, driven by soaring demand and low trading float, has propelled digital investment platform Groww's market value past that of one of the exchanges it listed on, making it the only broker to hold this feat.
3 mins
November 19, 2025
Mint New Delhi
Xiaomi’s EV business registers a profit for the first time
Xiaomi Corp. reported quarterly profit from its electric vehicle (EV) business for the first time, a major milestone for the smartphone maker's ambitious foray into the crowded market.
1 min
November 19, 2025
Mint New Delhi
Should wills be made in city of origin, or where the assets are?
I'm a Hindu man who has lived in Bengaluru for the past five years. I am originally from Mumbai. I own a flat near Koramangala in Bengaluru and do not have any property in Mumbai or anywhere else in the country. Should I make my will in Bengaluru or Mumbai, especially when considering stamp duty and related formalities?
2 mins
November 19, 2025
Mint New Delhi
UN Security Council backs Trump's plan for postwar Gaza
U.N. vote, on which China and Russia abstained, will pave way for new governance in Gaza
4 mins
November 19, 2025
Mint New Delhi
The COP is coy on fossil fuels
There is growing demand that COP30 in Brazil create a global roadmap for the end of oil, coal and gas
3 mins
November 19, 2025
Mint New Delhi
Microsoft, Nvidia to invest $15 bn in Anthropic
Microsoft Corp. and Nvidia Corp. are committing to invest upto a combined $15 billion in Anthropic PBC, in a move that ties the AI developer closer to two of the biggest backers for its rival OpenAI.
1 min
November 19, 2025
Mint New Delhi
Mining reform plan meets resistance in states
Mines ministry plans to limit premiums to 50% of ore value, replacing system where bids can cross even 100%
2 mins
November 19, 2025
Listen
Translate
Change font size